Online Pharmaceutical Schedule - May 2019
Measles, mumps and rubella vaccine [Xpharm]
Inj, measles virus 1,000 CCID50, mumps virus 5,012 CCID50, Rubella virus 1,000 CCID50; prefilled syringe/ampoule of diluent 0.5 ml
A maximum of two doses for any patient meeting the following criteria:
For primary vaccination in children; or
For revaccination following immunosuppression; or
For any individual susceptible to measles, mumps or rubella; or
A maximum of three doses for children who have had their first dose prior to 12 months.
Note: Please refer to the Immunisation Handbook for appropriate schedule for catch up programmes.